J&J CEO warns of 'unintended consequences' of Trump's drug-price reduction plan

May 17, 2018 , CNBC Health
"There are going to be changes in the pricing system" for prescription drugs, Johnson & Johnson chief Alex Gorsky acknowledges.

Read the full story...

Trending healthcare news keywords at this moment

congo ebola outbreak cancer drug treatment study risk patients bill care medical trump heart fda approves opioid tied disease blood prices tip healthcare women lower